Cargando…

COVID-19 serum can be cross-reactive and neutralizing against the dengue virus, as observed by the dengue virus neutralization test

OBJECTIVES: Observing the serological cross-reactivity between SARS-CoV-2 and dengue virus (DV), we aimed to elucidate its effect on dengue serodiagnosis and infectivity in a highly dengue-endemic city in India. METHODS: A total of 52 COVID-19 (reverse transcription-polymerase chain reaction [RT-PCR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nath, Himadri, Mallick, Abinash, Roy, Subrata, Kayal, Tathagata, Ranjan, Sumit, Sengupta, Susanta, Sukla, Soumi, Biswas, Subhajit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262656/ https://www.ncbi.nlm.nih.gov/pubmed/35811081 http://dx.doi.org/10.1016/j.ijid.2022.07.013

Ejemplares similares

Computational modelling supports that dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID-19 severity?
por: Nath, Himadri, et al.
Publicado: (2020)

Regarding: Masyeni S, Santoso MS, Widyaningsih PD, Wedha Asmara DG, Nainu F, Harapan H, et al. Serological cross-reaction and co-infection of dengue and COVID-19 in Asia: Experience from Indonesia. Int J Infect Dis 2020;102:152–4. https://doi.org/10.1016/j.ijid.2020.10.043
por: Biswas, Subhajit, et al.
Publicado: (2021)

Archived dengue serum samples produced false-positive results in SARS-CoV-2 lateral flow-based rapid antibody tests
por: Nath, Himadri, et al.
Publicado: (2021)

A Rapid and Easy-to-Perform Method of Nucleic-Acid Based Dengue Virus Diagnosis Using Fluorescence-Based Molecular Beacons
por: Sukla, Soumi, et al.
Publicado: (2021)

Non-cytopathic herpes simplex virus type-1 isolated from acyclovir-treated patients with recurrent infections
por: Roy, Subrata, et al.
Publicado: (2022)

Occult Hepatitis B Virus Infections (Often with Human Herpesvirus 7 Co-Infection) Detected in Pityriasis rosea Patients: A Pilot Study
por: De, Abhishek, et al.
Publicado: (2017)

Detection of Leptomonas seymouri narna-like virus in serum samples of visceral leishmaniasis patients and its possible role in disease pathogenesis
por: Sukla, Soumi, et al.
Publicado: (2022)

Neutralizing Antibodies after Infection with Dengue 1 Virus
por: Guzman, Maria G., et al.
Publicado: (2007)

A recombinant Fab neutralizes dengue virus in vitro
por: Thullier, P, et al.
Publicado: (1999)

Dengue Virus Neutralization in Cells Expressing Fc Gamma Receptors
por: Chawla, Tanu, et al.
Publicado: (2013)

Dengue Reporter Virus Particles for Measuring Neutralizing Antibodies against Each of the Four Dengue Serotypes
por: Mattia, Kimberly, et al.
Publicado: (2011)

Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement
por: Sarker, Animesh, et al.
Publicado: (2023)

Virus Reduction Neutralization Test: A Single-Cell Imaging High-Throughput Virus Neutralization Assay for Dengue
por: Whiteman, Melissa C., et al.
Publicado: (2018)

Complement-Mediated Neutralization of Dengue Virus Requires Mannose-Binding Lectin
por: Avirutnan, Panisadee, et al.
Publicado: (2011)

Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses
por: Wahala, Wahala M. P. B., et al.
Publicado: (2010)

Comparison of Neutralizing Dengue Virus B Cell Epitopes and Protective T Cell Epitopes With Those in Three Main Dengue Virus Vaccines
por: Pinheiro, Josilene Ramos, et al.
Publicado: (2021)

Optimization and Validation of a Plaque Reduction Neutralization Test for the Detection of Neutralizing Antibodies to Four Serotypes of Dengue Virus Used in Support of Dengue Vaccine Development
por: Timiryasova, Tatyana M., et al.
Publicado: (2013)

Genotype-specific and cross-reactive neutralizing antibodies induced by dengue virus infection: detection of antibodies with different levels of neutralizing activities against homologous and heterologous genotypes of dengue virus type 2 in common marmosets (Callithrix jacchus)
por: Azami, Nor Azila Muhammad, et al.
Publicado: (2018)

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
por: Halstead, SB, et al.
Publicado: (1977)

Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection
por: Collins, Matthew H., et al.
Publicado: (2017)

Reporter Virus Neutralization Test Evaluation for Dengue and Zika Virus Diagnosis in Flavivirus Endemic Area
por: Nunes, Jannyce G. C., et al.
Publicado: (2021)

Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue Virus
por: Brandler, Samantha, et al.
Publicado: (2007)

Induction of Neutralizing Antibodies against Four Serotypes of Dengue Viruses by MixBiEDIII, a Tetravalent Dengue Vaccine
por: Zhao, Hui, et al.
Publicado: (2014)

Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement
por: Fink, Ashley L., et al.
Publicado: (2017)

Correlation between Dengue-Specific Neutralizing Antibodies and Serum Avidity in Primary and Secondary Dengue Virus 3 Natural Infections in Humans
por: Puschnik, Andreas, et al.
Publicado: (2013)

Evaluation of a Novel Reporter Virus Neutralization Test for Serological Diagnosis of Zika and Dengue Virus Infection
por: Shan, Chao, et al.
Publicado: (2017)

Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virus
por: Katzelnick, Leah C., et al.
Publicado: (2018)

The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1
por: Shrestha, Bimmi, et al.
Publicado: (2010)

A novel reporter system for neutralizing and enhancing antibody assay against dengue virus
por: Song, Ke-Yu, et al.
Publicado: (2014)

Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis
por: Rainwater-Lovett, Kaitlin, et al.
Publicado: (2012)

Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513
por: Wong, Yee Hwa, et al.
Publicado: (2018)

Replication in the presence of dengue convalescent serum impacts Zika virus neutralization sensitivity and fitness
por: Marano, Jeffrey M., et al.
Publicado: (2023)

Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient
por: Schieffelin, John S, et al.
Publicado: (2010)

Dengue Mosaic Vaccines Enhance Cellular Immunity and Expand the Breadth of Neutralizing Antibody Against All Four Serotypes of Dengue Viruses in Mice
por: Hou, Jue, et al.
Publicado: (2019)

Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003)
por: White, Laura J., et al.
Publicado: (2021)

Genotypic Differences in Dengue Virus Neutralization Are Explained by a Single Amino Acid Mutation That Modulates Virus Breathing
por: Dowd, Kimberly A., et al.
Publicado: (2015)

Dengue Virus Neutralizing Antibody Levels Associated with Protection from Infection in Thai Cluster Studies
por: Buddhari, Darunee, et al.
Publicado: (2014)

Potent Neutralization Ability of a Human Monoclonal Antibody Against Serotype 1 Dengue Virus
por: Lu, Jiansheng, et al.
Publicado: (2018)

A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus
por: Xu, Meihui, et al.
Publicado: (2017)

Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes
por: Gallichotte, Emily N., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l2jprensjqliv25kigfgtls9g0